Stay updated on TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error and a Home option, replacing the study content and navigation with an error page that blocks access to the study record.
    Difference
    17%
    Check dated 2026-09-23T23:05:24.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page shows a new revision label: v3.7.0, replacing the previous v3.6.6. This indicates a minor update to the study record page rather than a change to the study data or visible content.
    Difference
    0.0%
    Check dated 2026-09-16T22:33:14.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.6.5 to v3.6.6, reflecting a newer version of the page. This update affects only the page version tag and does not modify study details or other visible content.
    Difference
    0.0%
    Check dated 2026-09-02T19:53:27.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    An NIH grant/contract funding note was added to the study identifiers, indicating NIH support for this trial.
    Difference
    0.0%
    Check dated 2026-08-26T20:50:33.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    An updated site revision number has been applied, changing from v3.6.4 to v3.6.5, which signals a behind-the-scenes update to the page's software or content management system. No study content or user-facing information appears to be affected.
    Difference
    0.0%
    Check dated 2026-08-12T21:33:37.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The revision label on the study page changed from v3.6.3 to v3.6.4, indicating a small update to the study record. It does not modify study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-07-22T09:54:28.000Z thumbnail image

Stay in the know with updates to TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.